Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286220 · ClinicalTrials.gov registry record · NA
Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT01286220: Clinical Trial NA study, sponsored by University of Texas Southwestern Medical Center.
NCT01286220 is a NA study that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01286220, a NA study, was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if twice weekly 10 minute dilute bleach baths decreases disease severity in patients with moderate to severe atopic dermatitis.
Primary Outcome
EASI score is recorded at baseline, 1 month and 3 month follow ups.
Interventions
- OTHER Water
- OTHER Dilute bleach baths
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2010-12 |
| Est. Completion | 2017-08 |
| Phase | NA |
Why NCT01286220 stopped before completion
NCT01286220 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.
NCT01286220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01286220 about?
NCT01286220 is a clinical study titled "Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis". The purpose of this study is to determine if twice weekly 10 minute dilute bleach baths decreases disease severity in patients with moderate to severe atopic dermatitis.
What is the current status of trial NCT01286220?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2010-12. Estimated completion is 2017-08.
What interventions are being tested in trial NCT01286220?
The interventions under investigation include: Water (OTHER), Dilute bleach baths (OTHER).
Who is sponsoring clinical trial NCT01286220?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01286220's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia